Moderna and UK Government Ink Partnership to Build mRNA Vaccine Research Facility
Moderna Inc will make investments in mRNA research and development (R&D) in the UK and construct a cutting-edge facility for
Read moreModerna Inc will make investments in mRNA research and development (R&D) in the UK and construct a cutting-edge facility for
Read moreThe manufacturing of machines for Continuous Manufacturing has begun. L.B. Bohle began production of the first machine at the new
Read moreBioEcho Life Sciences, specialist provider of today’s fastest and most sustainable nucleic acid extraction technology, receives two important hallmarks for
Read moreBased on continued success, L.B. BOHLE and KORSCH AG have announced the opening of a new facility in Hyderabad, India,
Read moreOri Biotech, based in the United Kingdom, has secured €88 million ($100 million) in its Series B funding to help
Read moreL.B. Bohle’s new metformin processing station allows for efficient and high-volume metformin production. Metformin is an oral drug effective for
Read moreBENEO’s galenIQ™ 721 filler-binder with improved technical properties is designed to optimise the production of fizzy tablets and powders. To
Read moreProtean offers a genetically modified Tick-Taq DNA Polymerase that has been optimised for all routine PCR applications providing greater sensitivity
Read moreA UK-based consortium consisting of BiologIC Technologies, Biopharm Services, CPI, Pall Corporation, and SCIEX has announced the start of a
Read moreProtean offers Non-specific Endonuclease isolated from Serratia marcescens, which is a highly processive enzyme active under a variety of conditions
Read more